About 50 results
Open links in new tab
  1. Semaglutide - ALZFORUM

    Semaglutide is a synthetic, long-acting analog of glucagon-like peptide-1, used to treat diabetes and obesity. Ozempic TM is a once-per-week injection formulation, while Rybelsus TM is a daily pill.

  2. Semaglutide Does Not Treat Alzheimer’s. Could It Prevent Dementia?

    Semaglutide mildly shifted some CSF AD biomarkers, although the drug is not expected to reduce amyloid. Some scientists believe semaglutide could prevent AD or other dementias, if started earlier.

  3. Novel LC-MS/MS analysis of the GLP-1 analog semaglutide with its ...

    Lee TS, Park EJ, Choi M, Oh HS, An Y, Kim T, Kim TH, Shin BS, Shin S. Novel LC-MS/MS analysis of the GLP-1 analog semaglutide with its application to pharmacokinetics and brain distribution studies …

  4. Semaglutide ameliorates cognition and glucose metabolism

    Dec 1, 2023 · Semaglutide ameliorates cognition and glucose metabolism dysfunction in the 3xTg mouse model of Alzheimer's disease via the GLP-1R/SIRT1/GLUT4 pathway. Neuropharmacology. …

  5. NT-0796 | ALZFORUM

    Dec 17, 2025 · Background NT-0796 is an oral, brain-penetrant inhibitor of inflammasomes that contain NLRP3, aka nod-like receptor family pyrin domain-containing protein 3. Inflammasomes are …

  6. Could GLP-1 Receptor Agonists Like Semaglutide Treat Addiction ...

    Rubin R. Could GLP-1 Receptor Agonists Like Semaglutide Treat Addiction, Alzheimer Disease, and Other Conditions?. JAMA. 2024 May 14;331 (18):1519-1521. PubMed.

  7. The Discovery and Development of Liraglutide and Semaglutide

    Knudsen LB, Lau J. The Discovery and Development of Liraglutide and Semaglutide. Front Endocrinol (Lausanne). 2019;10:155. Epub 2019 Apr 12 PubMed.

  8. Semaglutide is Neuroprotective and Reduces α-Synuclein Levels in the ...

    Zhang L, Zhang L, Li L, Hölscher C. Semaglutide is Neuroprotective and Reduces α-Synuclein Levels in the Chronic MPTP Mouse Model of Parkinson's Disease. J Parkinsons Dis. 2019;9 (1):157-171.

  9. Baseline Characteristics from Evoke and Evoke+: Two Phase 3 …

    Scheltens P, Atri A, Feldman H, Hansson O, Knop F, Sano M, Dethlefsen C, Johannsen P, León T, Hansen CT, Cummings J. Baseline Characteristics from Evoke and Evoke+: Two Phase 3 …

  10. ALZFORUM | NETWORKING FOR A CURE

    5 days ago · Finger-Prick Blood Test Accurately Measures Alzheimer’s Biomarkers Phlebotomy isn’t quite going the way of the horse and buggy yet, but a drop of blood from a finger prick sufficed to …